Equine Chorionic Gonadotropin (eCG) Market Research:the global market size is projected to reach USD 0.37 billion by 2031

QY Research Inc. (Global Market Report Research Publisher) announces the release of 2025 latest report “Equine Chorionic Gonadotropin (eCG)- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031”. Based on current situation and impact historical analysis (2020-2024) and forecast calculations (2025-2031), this report provides a comprehensive analysis of the global  Equine Chorionic Gonadotropin (eCG)  market, including market size, share, demand, industry development status, and forecasts for the next few years.

The global market for Equine Chorionic Gonadotropin (eCG) was estimated to be worth US$ 269 million in 2024 and is forecast to a readjusted size of US$ 374 million by 2031 with a CAGR of 4.7% during the forecast period 2025-2031.

【Get a free sample PDF of this report (Including Full TOC, List of Tables & Figures, Chart)】 
https://www.qyresearch.com/reports/4941024/equine-chorionic-gonadotropin–ecg

According to the new market research report “Equine Chorionic Gonadotropin (eCG) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031”, published by QYResearch, the global Equine Chorionic Gonadotropin (eCG) market size is projected to reach USD 0.37 billion by 2031, at a CAGR of 4.7% during the forecast period.

Figure00001. Global Equine Chorionic Gonadotropin (eCG) Market Size (US$ Million), 2020-2031

Source: QYResearch, “Equine Chorionic Gonadotropin (eCG) – Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031”

Figure00002. Global Equine Chorionic Gonadotropin (eCG) Top 10 Players Ranking and Market Share (Ranking is based on the revenue of 2024, continually updated)

Source: QYResearch, “Equine Chorionic Gonadotropin (eCG) – Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031”

According to QYResearch Top Players Research Center, the global key manufacturers of Equine Chorionic Gonadotropin (eCG) include MSD Animal Health, Ceva Santé Animale, Ningbo Sansheng Biological Technology, Ningbo Second Hormone Factory, Syntex SA, etc. In 2024, the global top five players had a share approximately 74.0% in terms of revenue.

Figure00003. Equine Chorionic Gonadotropin (eCG), Global Market Size, Split by Type

Source: QYResearch, “Equine Chorionic Gonadotropin (eCG) – Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031”

In terms of product type, currently 5000IU/Units is the largest segment, hold a share of 40%.

Figure00004. Equine Chorionic Gonadotropin (eCG), Global Market Size, Split by Application Segment

Source: QYResearch, “Equine Chorionic Gonadotropin (eCG) – Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031”

In terms of product application, currently Pigs is the largest segment, hold a share of 64%.

Figure00005. Equine Chorionic Gonadotropin (eCG), Global Market Size, Split by Region（Consumption）

Source: QYResearch, “Equine Chorionic Gonadotropin (eCG) – Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031”

Currently, Europe is the most important consumer market, accounting for about 40% of the market share.

The report provides a detailed analysis of the market size, growth potential, and key trends for each segment. Through detailed analysis, industry players can identify profit opportunities, develop strategies for specific customer segments, and allocate resources effectively.

The Equine Chorionic Gonadotropin (eCG) market is segmented as below:
By Company
MSD Animal Health
Ceva Santé Animale
Syntex SA
Bioveta
Ningbo Sansheng Biological Technology
Ningbo Second Hormone Factory
Chifeng Bo-en Pharmaceutical
Guangzhou Vbio-Pharma
JALLY
Ningbo Creator Animal Pharmaceutical

Segment by Type
1000IU/Units
5000IU/Units
Others

Segment by Application
Pigs
Cattles
Sheeps
Horses
Other Animals

Each chapter of the report provides detailed information for readers to further understand the Equine Chorionic Gonadotropin (eCG) market:

Chapter 1: Introduces the report scope of the Equine Chorionic Gonadotropin (eCG) report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry. (2020-2031)
Chapter 2: Detailed analysis of Equine Chorionic Gonadotropin (eCG) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc. (2020-2025)
Chapter 3: Provides the analysis of various Equine Chorionic Gonadotropin (eCG) market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments. (2020-2031)
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.(2020-2031)
Chapter 5:  Sales, revenue of Equine Chorionic Gonadotropin (eCG) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world..(2020-2031)
Chapter 6:  Sales, revenue of Equine Chorionic Gonadotropin (eCG) in country level. It provides sigmate data by Type, and by Application for each country/region.(2020-2031)
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc. (2020-2025)
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Benefits of purchasing QYResearch report:
Competitive Analysis: QYResearch provides in-depth Equine Chorionic Gonadotropin (eCG) competitive analysis, including information on key company profiles, new entrants, acquisitions, mergers, large market shear, opportunities, and challenges. These analyses provide clients with a comprehensive understanding of market conditions and competitive dynamics, enabling them to develop effective market strategies and maintain their competitive edge.

Industry Analysis: QYResearch provides Equine Chorionic Gonadotropin (eCG) comprehensive industry data and trend analysis, including raw material analysis, market application analysis, product type analysis, market demand analysis, market supply analysis, downstream market analysis, and supply chain analysis.

and trend analysis. These analyses help clients understand the direction of industry development and make informed business decisions.

Market Size: QYResearch provides Equine Chorionic Gonadotropin (eCG) market size analysis, including capacity, production, sales, production value, price, cost, and profit analysis. This data helps clients understand market size and development potential, and is an important reference for business development.

Other relevant reports of QYResearch:
Global Equine Chorionic Gonadotropin (eCG) Market Outlook, InDepth Analysis & Forecast to 2031
Global Equine Chorionic Gonadotropin (eCG) Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
Global Equine Chorionic Gonadotropin (eCG) Market Research Report 2025
Equine Chorionic Gonadotropin (eCG)- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Global Equine Chorionic Gonadotropin (eCG) for Injection Market Outlook, InDepth Analysis & Forecast to 2031
Global Equine Chorionic Gonadotropin (eCG) for Injection Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
Equine Chorionic Gonadotropin (eCG) for Injection- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Global Equine Chorionic Gonadotropin (eCG) for Injection Market Research Report 2025

About Us：
QYResearch founded in California, USA in 2007, which is a leading global market research and consulting company. Our primary business include market research reports, custom reports, commissioned research, IPO consultancy, business plans, etc. With over 18 years of experience and a dedicated research team, we are well placed to provide useful information and data for your business, and we have established offices in 7 countries (include United States, Germany, Switzerland, Japan, Korea, China and India) and business partners in over 30 countries. We have provided industrial information services to more than 60,000 companies in over the world.

Contact Us:
If you have any queries regarding this report or if you would like further information, please contact us:
QY Research Inc.
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
EN: https://www.qyresearch.com
Email: global@qyresearch.com
Tel: 001-626-842-1666(US)
JP: https://www.qyresearch.co.jp